Novavax stock surges after hours on coronavirus funding, results – MarketWatch
Business News
- Novavax stock surges after hours on coronavirus funding, results MarketWatch
- Why Novavax Shares Are Soaring Today Motley Fool
- Vaccine Company Novavax Gets $388 Million Grant For Coronavirus Vaccine Forbes
- Epidemic Response Group to Invest Up to $384 Million in Novavax’s Coronavirus Vaccine The New York Times
- Novavax Jumps on $388 Million Funding From Vaccine Coalition Bloomberg
- View Full Coverage on Google News
Source: Business News